Literature DB >> 32868026

Diagnostic value of modified systemic inflammation score for prediction of malignancy in patients with indeterminate thyroid nodules.

Hakan Ataş1, Birol Korukluoğlu2, Buket Altun Özdemir2, Neşe Yakşi3, Barış Saylam2, Mesut Tez4.   

Abstract

BACKGROUND: Approximately 20% of the thyroid biopsies render an indeterminate (ID) cytology. We evaluated the diagnostic value of preoperative modified systemic inflammation score (mSIS) in predicting the malignancy of ID thyroid nodules (TNs).
METHODS: Data of 162 patients with indeterminate TNs were examined retrospectively. The mSIS was calculated as follows: mSIS 0 [patients with albumin (ALB) ≥ 4.0 g/dL and lymphocyte-to-monocyte ratio (LMR) ≥ 3.4], mSIS 1 [ALB < 4.0 g/dL or LMR < 3.4], and mSIS 2 [ALB < 4.0 g/dL and LMR < 3.4].
RESULTS: Patients were classified into mSIS 0 (n = 105), mSIS 1 (n = 34) and mSIS 2 (n = 23) groups. The malignancy rates for the mSIS 0, 1 and 2 groups were 34.3%, 64.7% and 100% respectively. Preoperative mSIS was significantly associated with the presence of thyroid malignancy (p < 0.001).
CONCLUSIONS: If the mSIS of patients with ID cytology is 1 or 2, appropriate surgical treatment should be performed without delay, due to the increased risk of malignancy.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Albumin; Lymphocyte-to-monocyte ratio; Systemic inflammation score; Thyroid cancer; Thyroid nodules

Mesh:

Year:  2020        PMID: 32868026     DOI: 10.1016/j.amjsurg.2020.08.002

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Can preoperative modified systemic inflammation score (mSIS) be used to predict malignancy in persistent nondiagnostic thyroid nodules?

Authors:  Hakan Ataş; Bİrol Korukluoğlu; Bülent Çomçali; Neşe Yakşi; Barış Saylam; Mesut Tez
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

2.  Prognostic Evaluation of Metastasis-Related Lymphocyte/Monocyte Ratio in Stage Ⅰ-Ⅲ Breast Cancer Receiving Chemotherapy.

Authors:  Zihan Zhang; Qian Lin; Yi Chen; Chenlin Su; Wuye Lin; Daoyu Wei; Litu Zhang; Haizhou Liu
Journal:  Front Oncol       Date:  2022-03-24       Impact factor: 6.244

3.  Predictive value of modified systemic inflammation score for postoperative unplanned ICU admission in patients with NSCLC.

Authors:  Zhulin Wang; Hua Zhang; Chunyao Huang; Kaiyuan Li; Wenqing Luo; Guoqing Zhang; Xiangnan Li
Journal:  Front Surg       Date:  2022-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.